Irish biotech startup Aerska secured $39M in funding to develop technology that delivers RNA-based medicines across the blood-brain barrier. The company aims to treat neurodegenerative diseases like Alzheimer's and Parkinson's by targeting disease-causing proteins at their genetic source, rather than just managing symptoms. The

3m read time From thenextweb.com
Post cover image
Table of contents
Crossing the brain’s final frontierLongevity, but grounded in reality

Sort: